Ashlee Duncan

Ashlee Duncan is a seasoned professional in medical writing and regulatory affairs, currently serving as Senior Director and Head of Medical Writing at Merz Aesthetics since February 2016. In this role, Ashlee contributes scientific expertise to clinical strategy development, study design, and data communication while guiding cross-functional teams to ensure compliance with regulatory standards. Previous experiences include leadership positions at BioSignia, Inc., where Ashlee was pivotal in securing FDA registrations for health risk assessment models, and GlaxoSmithKline, where Ashlee co-led pharmacoepidemiology studies. Educational qualifications include a PhD in Epidemiology and an MS in Toxicology from North Carolina State University, complemented by a BS in Environmental Health Science from The University of Georgia.